Pemetrexed with simplified folate and dexamethasone supplementation versus pemetrexed with standard supplementation as second-line chemotherapy for patients with non-small cell lung cancer.

Trial Profile

Pemetrexed with simplified folate and dexamethasone supplementation versus pemetrexed with standard supplementation as second-line chemotherapy for patients with non-small cell lung cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2012

At a glance

  • Drugs Dexamethasone; Folic acid; Pemetrexed; Vitamin B12 analogues
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Planned end date changed from 1 Feb 2011 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 05 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top